肝硬化患者诊断中运用生化检验的临床价值

To Explain the Clinical Value of Biochemical Test in the Diagnosis of Cirrhosis

目的探讨肝硬化患者诊断中使用生化检验的临床价值分析。方法选取本院2015年6月—2017年6月收治的50例肝硬化患者作为临床研究对象,并选择同期检查身体健康的50人进行对照,两组患者均给予生化检验检查,并统一整理生化检验检查各项结果,对两组检查对象的检查结果进行对比。结果两组研究对象经过检查后发现,在丙氨酸转氨酶、谷草转氨酶、直接胆红素等比较中观察组患者比对照组患者高;在胆碱酯酶、白蛋白、总蛋白数据对比中,观察组患者显著比对照组低(P<0.05)。结论在肝硬化疾病诊断中使用生化检验,然后通过配合患者的影像学检查报告等进行分析,实现了对患者肝脏状况的有效检查,并为治疗方案提供了充足的参考依据,对肝硬化疾病检验、预防等具有极高利用价值。

Objective To evaluate the clinical value of biochemical tests in the diagnosis of cirrhosis.Methods Fifty cases of liver cirrhosis patients in our hospital from June 2015 to June 2017 were selected,and 50 healthy subjects were used as controls.Biochemical test results were compared between the two groups.Results The patients,biochemi cal indexes in the observation group were significantly lower than the control group(P<0.05).Conclusion Biochemical test in the diagnosis of cirrhosis is of high value for inspection and prevention of liver disease.